Haemonetics Co. Expected to Post Q1 2024 Earnings of $0.73 Per Share (NYSE:HAE)
Haemonetics Co. (NYSE:HAE – Get Rating) – Research analysts at Zacks Research issued their Q1 2024 earnings estimates for Haemonetics in a report released on Wednesday, May 24th. Zacks Research analyst R. Anand anticipates that the medical instruments supplier will post earnings of $0.73 per share for the quarter. The consensus estimate for Haemonetics’ current […]